ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Kidney Week 2025: Exhibitor Spotlight Schedule

Thursday, November 6 - Saturday, November 8

George R. Brown Convention Center, Exhibit Hall D

Join your colleagues for the latest advances in nephrology practices, products, services, and technologies presented in three theaters on the exhibit hall floor. Seating is limited and available on a first-come, first-served basis to fully registered Kidney Week participants only. Exhibitor Spotlights are not CE (continuing education) activities.

The 10:00 a.m. presentations include breakfast. All other presentations include lunch.

Thursday, November 6

10:00-10:45 a.m.
HighVolumeHDF: The Next Standard of Care for US Patients - Evidence and Practical Use
Presented by Fresenius Medical Care

11:00-11:45 a.m.
Global Pathways to Home: Strategies for Success
Presented by Vantive Healthcare

11:30 a.m.-12:15 p.m.
Expert Perspectives and Patient Experiences: Upgrading to a Stronger Foundation in IgA Nephropathy
Presented by Travere Therapeutics

12:00-12:45 p.m.
Advancing Care in Lupus Nephritis: Exploring the Evolving Landscape
Presented by Genentech

12:30-1:15 p.m.
Houston, We Have a Solution: Integrating Genetics into Clinical Practice
Presented by Natera

1:00-1:45 p.m.
B-cell Modulation in IgA Nephropathy
Presented by Otsuka

Friday, November 7

10:00-10:45 a.m.
Decoding a Silent Threat: Aldosterone's Impact on Hypertension and Cardiovascular and Renal Morbidity
Presented by AstraZeneca

11:00-11:45 a.m.
Expanding Perspectives in Hyperphosphatemia Treatment; A Different Approach
Presented by Ardelyx, Inc.

11:30 a.m.-12:15 p.m.
IgA Nephropathy Paradigm Shift: KDIGO Guidelines and the Centrality of B Cells
Presented by Vertex Pharmaceuticals

12:00-12:45 p.m.
Hypoxia-Inducible Factor Activation & Erythropoietic Effects in Anemia due to CKD
Presented by Akebia Therapeutics

12:30-1:15 p.m.
Navigating the Crossroads of IgAN: 2 Distinct Paths to Reducing Proteinuria
Presented by Novartis Pharmaceuticals

1:00-1:45 p.m.
Targeting IgAN Early: Considerations for Adding Potentially Disease Modifying Therapy to Frontline Treatment
Presented by Calliditas Therapeutics

Saturday, November 8

10:00-10:45 a.m.
Optimizing Transitions of Care in Kidney Transplantation: The Role of Envarsus XR®
Presented by Veloxis Pharmaceuticals, Inc.

11:00-11:45 a.m.
Jardiance® (empagliflozin) tablets: Expert Perspectives on Clinical Trial Data and Approved Indications
Presented by Boehringer Ingelheim/Lilly USA

11:30 a.m.-12:15 p.m.
Taking a Different Direction in the Treatment of Primary Hyperoxaluria Type 1 (PH1)
Presented by Novo Nordisk

12:00-12:45 p.m.
Role of CD38+ Cells in Immune-Mediated Kidney Disease
Presented by Biogen

12:30-1:15 p.m.
Translating KDIGO Guidelines into Therapeutic Goals in IgA Nephropathy
Presented by Vera Therapeutics

1:00-1:45 p.m.
DefenCath® Indication, Use and Navigating Reimbursement Across Settings of Care
Presented by CorMedix

Additional information, if provided by the supporter, is available by clicking on the presentation title.